Highvista Strategies LLC / RVMD
Highvista Strategies LLC’s Revolution Medicines Inc Position
Does Highvista Strategies LLC own Revolution Medicines Inc (RVMD)? Yes — 69.3K shares worth $7M (+1.86% of its 13F portfolio) as of Q1 2026, down from 120.2K shares the prior filed quarter.
Position Value
$7M
Q1 2026
Shares
69.3K
% of Portfolio
+1.86%
Quarters Held
16
currently held
Position History RVMD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 69.3K | $7M | +1.86% |
| Q4 2025 | 120.2K | $10M | +2.47% |
| Q3 2025 | 175.4K | $8M | +2.01% |
| Q2 2025 | 68.0K | $3M | +0.92% |
| Q1 2025 | 73.8K | $3M | +1.00% |
| Q4 2024 | 57.2K | $3M | +0.93% |
| Q3 2024 | 55.6K | $3M | +0.87% |
| Q2 2024 | 40.1K | $2M | +0.57% |
| Q1 2024 | 14.3K | $461,695 | +0.16% |
| Q4 2023 | 22.6K | $649,602 | +0.24% |
| Q3 2023 | 18.0K | $498,378 | +0.23% |
| Q3 2022 | 42.1K | $829,000 | +0.47% |
| Q2 2022 | 20.7K | $403,000 | +0.24% |
| Q3 2021 | 23.6K | $650,000 | +0.43% |
| Q2 2021 | 25.0K | $795,000 | +0.56% |
| Q1 2021 | 17.0K | $780,000 | +0.58% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of RVMD.